Skip to main content
Equibles
APYX logo

APYX

Apyx Medical Corp
$4.30 -0.36 (-7.73%) At close · Jul 2
Market Cap
$180.06M
Shares
41,873,951

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$4.30 Open$4.70 Day$4.27–4.85 52W$1.59–5.08 Avg vol 30d150K Short int140K · 0.3% float · 1.0d Short vol16% Last earningsMay 7, 2026 DataJan 2020–Jul 2026 Filing10-Q · May 7
Equibles Rating blended score · not investment advice
Overall
Buy
Technical · trend & momentum Buy
◦ 50 / 200-day cross no cross
+ Price vs 200-day avg +18% above
+ Price vs 50-day avg +7% above
◦ RSI (14) 50 · neutral
− MACD trend negative
◦ 52-week position 78% · mid-range
Sentiment · smart money Bullish
◦ Trend (MA cross) 50d $4 › 200d $4 — 50d above 200d
+ Institutional flow +14% holders QoQ · +16 funds added
◦ Insider flow No net insider activity over 90 days
+ Short interest 0.33% of float · ▼ -34.1% MoM · 1.0 days cover
◦ Volume signal Volume near normal
+ Institution breadth 67 holders — near 3-yr high, broad support
Fundamentals Strong
+ Revenue growth +10% Y/Y
+ Gross margin 63%, expanding
+ EPS growth +19% Y/Y
− Free cash flow $-9.1M
◦ Balance sheet net debt $5.8M

Blended from price, positioning & fundamentals · daily-close · not investment advice.

Up next
Next earnings call
Aug 6, 2026 Est · unconfirmed · in 4 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed May 7, 2026
AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Guidance & track record
      Latest guidance · from the 8-K filed May 7, 2026
      Total revenue · full year 2026 Initiated $59M – $60M
      prior FY $52.84M midpoint +12.6% Y/Y
      Surgical Aesthetics revenue · full year 2026 Initiated $54M – $55M
      OEM revenue · full year 2026 Initiated $5M
      Operating expenses · full year 2026 Initiated up to $45M

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Buy
      1 · 3 · 2
      50 / 200-day cross
      no cross Neutral
      Price vs 200-day avg
      +18% above Bullish
      Price vs 50-day avg
      +7% above Bullish
      RSI (14)
      50 · neutral Neutral
      MACD trend
      negative Bearish
      52-week position
      78% · mid-range Neutral
      Market signals — smart money & positioning
      Bullish · 3 of 6
      Trend (MA cross) No cross
      50d $4 › 200d $4 — 50d above 200d
      Institutional flow Accumulating
      +14% holders QoQ · +16 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Falling
      0.33% of float · ▼ -34.1% MoM · 1.0 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      67 holders — near 3-yr high, broad support
      Price context
      position in its 52-week range
      52-wk low $2 Now $4 · 78% 52-wk high $5
      vs 200-day avg +18% vs 50-day avg +7%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from its earnings releases, calls, and filings
      Metric Latest Period YoY
      Adjusted EBITDA loss non-GAAP -$0.3M Q1 2026 —
      Adjusted EBITDA non-GAAP $0.7M the three months ended December 31, 2025 —

      Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file

      Versus peers

      Medical Devices — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      APYX
      Apyx Medical Corp
      this stock
      		$180.06M +22.9% +9.9% — 0.3%
      ABT
      Abbott Laboratories
      		 $166.17B -23.5% +5.7% 26.7 1.3%
      SYK
      Stryker Corp
      		 $125.18B -6.8% +11.2% 37.8 1.6%
      MDT
      Medtronic plc
      		 $106.49B -12.7% +8.4% 22.3 1.4%
      BSX
      Boston Scientific Corp
      		 $67.09B -52.7% +5.5% 18.9 2.0%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      67
      % held
      49.9%
      Net QoQ
      +1.6M sh
      Top holder
      Nantahala Capital Managem…
      Held Float
      View
      Held by Funds
      Fund positions
      24
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      139.7K
      Days to cover
      1.0d
      Change
      -72.3K sh
      View
      Short Volume
      Short vol %
      16%
      As of
      Jul 2, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      1.8K
      Value
      $8.2K
      As of
      Jun 8, 2026
      View
      Off-Exchange
      Off-exchange %
      55.0%
      Week of
      May 4, 2026
      Off-exch Lit
      View
      Financials
      Financials
      Revenue (FY)
      $52.8M
      Net income (FY)
      $-11.2M
      EPS diluted
      $-0.54
      View
      Filings
      SEC Filings
      Latest
      DEF 14A
      Filed
      Jun 26, 2026
      This year
      10
      View
      Proposed Sales
      Value
      $105.3K
      Shares
      15.0K
      Filed
      Jun 21, 2023
      View
      Earnings & Events
      Earnings Calls
      Last call
      May 7, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      APYX +3.1% +13.5% +24.3% -4.2% +22.9%
      SPY +1.4% -1.3% +8.0% -0.3% +9.2%
      vs SPY +1.7% +14.7% +16.3% -4.0% +13.6%
      Key facts CIK 719135 CUSIP 03837C106 Visit website

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)